Citigroup
BLFS icon

Citigroup’s BioLife Solutions BLFS Stock Holding History

Citigroup’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$228K – 5657
2025
Q1 		$228K Buy
+10,000
New +$263K ﹤0.01% 4128

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citigroup's BLFS Position: Q1 2026 in Review

Citigroup reduced its BioLife Solutions (BLFS) stake by 48% in Q1 2026, selling an estimated $433K and leaving 21,384 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Citigroup first reported a position in BLFS in Q3 2014 and has held it in 33 quarters since. The position peaked at $1.78M in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Citigroup held 21,384 shares of BioLife Solutions worth $408K as of Q1 2026.
  • Citigroup sold 19,595 BioLife Solutions shares in Q1 2026, an estimated $433K.
  • BioLife Solutions made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3664 holding.
  • Citigroup first reported a position in BioLife Solutions in Q3 2014 and has held it in 33 quarters since.
  • Citigroup's BioLife Solutions position peaked at $1.78M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.